Abstract
Quality by design (QbD) (US FDA, Quality by design for ANDAs: an example for immediate-release dosage forms, 2012) approach in product development has become a norm as Regulatory Agencies are basing their decisions on submitted product on the review of the scientific information generated and presented in a systematic way. It reduces the issues and burden at process validation stage and throughout the commercial manufacture. Consequently, it reduces the need for post approval changes driven by processing issues but also facilitates approval of process improvement changes that may fall within the originally studied design space.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
